Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors

Timothy Kottke1, Fiona Errington, Jose Pulido

  • 1Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Nature Medicine
|June 21, 2011
PubMed

Insights

A novel cancer immunotherapy using a cDNA library expressed from a viral platform effectively cures tumors. This approach presents diverse tumor antigens, reducing treatment resistance and offering a new paradigm for cancer therapy.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Effective cancer immunotherapy necessitates broad tumor antigen release and robust immune activation.
  • Existing immunotherapies face challenges with immune escape and treatment resistance.

Purpose of the Study:

  • To investigate a novel cancer treatment strategy using a cDNA library expressed from a viral platform.
  • To evaluate the efficacy of this approach in curing established tumors and overcoming immune escape.

Main Methods:

  • A cDNA library derived from normal tissue was expressed using a highly immunogenic viral platform.
  • The therapy was tested on established tumors of the same histological type as the cDNA source.
  • Suboptimal vaccination and subsequent immune escape were assessed, followed by second-line immunotherapy.

Main Results:

  • The virus-expressed cDNA library successfully cured established tumors.
  • Immune escape was observed with suboptimal vaccination but was overcome by second-line immunotherapy.
  • The approach presented a broad repertoire of tumor-associated antigens, minimizing treatment-resistant variants.

Conclusions:

  • Virus-expressed cDNA libraries offer a novel paradigm for cancer treatment.
  • This strategy addresses key limitations in current immunotherapies and virotherapies.
  • The method allows for systemic delivery, broad antigen presentation, and potential for combination therapies.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...